Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CASTLE BIOSCIENCES INC | 1,633,577 | reported | 12 May 2020 | tx 15+1,833,586−2,332,235 |
| Xeris Biopharma Holdings, Inc. | 214,144 | reported | 04 Jun 2025 | tx 19+551,038 |
| Venus Concept Inc. | 75,000 | reported | 24 Mar 2023 | tx 15+9,651,255−120,000 |
| Ocugen, Inc. | 25,000 | reported | 15 Jun 2018 | tx 4+80,000 |
| CEMPRA, INC. | 9,100 | reported | 12 Jun 2018 | tx 9+144,930 |
| ALIMERA SCIENCES INC | 6,000 | reported | 04 Jan 2023 | tx 12+257,833 |
| LABCORP HOLDINGS INC. | 773 | reported | 11 Feb 2026 | tx 40+28,153−13,739 |
| Strongbridge Biopharma plc | 0 | reported | 05 Oct 2021 | tx 9+160,000−274,385 |
| AVEDRO INC | 0 | reported | 21 Nov 2019 | tx 12+1,338,881−2,633,120 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Feb 2026 | EXERCISE | LABCORP HOLDINGS INC. | 897 | — | |
| 11 Feb 2026 | EXERCISE | LABCORP HOLDINGS INC. | 897 | 0.00 USD | deriv |
| 10 Feb 2026 | GRANT_AWARD | LABCORP HOLDINGS INC. | 773 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 50,000 | 0.00 USD | |
| 11 Feb 2025 | GRANT_AWARD | LABCORP HOLDINGS INC. | 897 | 0.00 USD | deriv |
| 06 Feb 2025 | EXERCISE | LABCORP HOLDINGS INC. | 944 | — | |
| 06 Feb 2025 | EXERCISE | LABCORP HOLDINGS INC. | 944 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 50,000 | 0.00 USD | |
| 15 Mar 2024 | OTHER | Xeris Biopharma Holdings, Inc. | 6,474 | — | |
| 07 Feb 2024 | EXERCISE | LABCORP HOLDINGS INC. | 947 | — | |
| 06 Feb 2024 | GRANT_AWARD | LABCORP HOLDINGS INC. | 944 | 0.00 USD | deriv |
| 07 Feb 2024 | EXERCISE | LABCORP HOLDINGS INC. | 947 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 42,500 | 0.00 USD | |
| 24 Mar 2023 | GRANT_AWARD | Venus Concept Inc. | 75,000 | 0.00 USD | deriv |
| 11 Feb 2023 | EXERCISE | LABCORP HOLDINGS INC. | 742 | — | |
| 11 Feb 2023 | EXERCISE | LABCORP HOLDINGS INC. | 742 | 0.00 USD | deriv |
| 07 Feb 2023 | GRANT_AWARD | LABCORP HOLDINGS INC. | 849 | 0.00 USD | deriv |
| 04 Jan 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 6,000 | 0.00 USD | deriv |
| 18 Nov 2022 | PURCHASE | Venus Concept Inc. | 335,000 | 2.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 15,000 | 0.00 USD | |
| 08 Jun 2022 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 25,000 | 0.00 USD | deriv |
| 25 Mar 2022 | GRANT_AWARD | Venus Concept Inc. | 25,000 | 0.00 USD | deriv |
| 11 Feb 2022 | GRANT_AWARD | LABCORP HOLDINGS INC. | 742 | 0.00 USD | deriv |
| 02 Feb 2022 | EXERCISE | LABCORP HOLDINGS INC. | 771 | — | |
| 02 Feb 2022 | EXERCISE | LABCORP HOLDINGS INC. | 771 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 15 Dec 2021.